Rush University Medical Center — Biomedical Watch V2

Essais liés32clinical trials

VilleChicagolocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07100080

Ouvrir le site du centre

Essais cliniques associés

Molécule	Indication / population	Phase	NCT	Titre	Statut
BIA 28-6156 10 mg	Parkinson	Phase 2	NCT05819359	ACTIVATE — Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD	COMPLETED
NRTX-1001	Épilepsie	Phase 3	NCT05135091	Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))	RECRUITING
RapidPulseTM Aspiration System	Accident vasculaire cérébral	Non applicable	NCT06029491	TURBO — Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions	RECRUITING
Lebrikizumab	SEP	Phase 3	NCT01875003	A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication	TERMINATED
Surgical management	Accident vasculaire cérébral	Non applicable	NCT06870812	REACH — Rapid Evacuation and Access of Cerebral Hemorrhage Trial	RECRUITING
AFSW Guided DOAC	Accident vasculaire cérébral	Phase 3	NCT05836987	REACT-AF — The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation	RECRUITING
Investigational PFO Closure Device	Accident vasculaire cérébral	Non applicable	NCT05069558	OCCLUFLEX — Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion	ACTIVE_NOT_RECRUITING
Pelacarsen (TQJ230)	Accident vasculaire cérébral	Phase 3	NCT07517263	An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)	ACTIVE_NOT_RECRUITING
Iza-bren	Cancer	Phase 2/3	NCT07100080	Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)	RECRUITING
cemacabtagene ansegedleucel	SEP	Phase 2	NCT06500273	ALPHA3 — Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL	RECRUITING
GammaTile®	Cancer	Phase 3	NCT07195591	BRIDGES — Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care	RECRUITING
ASSUAGE Protocol	SEP	Phase 4	NCT01655524	ASSUAGE-MPI — The Impact of the Routine Aminophylline Administration Following Regadenoson Stress on SPECT Myocardial Perfusion	WITHDRAWN
Irreversible Electroporation	Cancer	Non applicable	NCT04972097	PRESERVE — Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue	COMPLETED
Ocrelizumab	SEP	Phase 4	NCT04377555	Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab	COMPLETED
Low Dose Benfotiamine	Alzheimer	Phase 2	NCT06223360	A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)	ACTIVE_NOT_RECRUITING
NanoKnife Procedure	Cancer	Non applicable	NCT01972867	Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients	UNKNOWN
Ubamatamab	Cancer	Phase 2	NCT07154290	A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)	RECRUITING
TREAT-MS — Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial	SEP	Non applicable	NCT03500328	TREAT-MS — Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial	ACTIVE_NOT_RECRUITING
RE104 for Injection	Sclérose latérale amyotrophique	Phase 2	NCT07002034	RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	RECRUITING
Mycophenolate Mofetil	Myasthénie	À vérifier	NCT03490539	PROMISE-MG — Disease-Modifying Treatments for Myasthenia Gravis	COMPLETED
Litifilimab	Lupus	Phase 2/3	NCT05531565	AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus	ACTIVE_NOT_RECRUITING
Histotripsie — HistoSonics Edison System	Cancer	À vérifier	NCT06486454	Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)	RECRUITING
CT1812	Alzheimer	Phase 2	NCT05531656	A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease	ACTIVE_NOT_RECRUITING
extended release metformin	Alzheimer	Phase 2/3	NCT04098666	MAP — Metformin in Alzheimer's Dementia Prevention	ACTIVE_NOT_RECRUITING
Deep Brain Stimulation (DBS)	Parkinson	À vérifier	NCT02071134	Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry	RECRUITING
Remibrutinib oral treatment	SEP	Phase 3	NCT06846281	Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.	RECRUITING
APL-130277	Parkinson	Phase 3	NCT02542696	Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease	COMPLETED
In-Home Care for Patients With Parkinson's Disease	Parkinson	NA	NCT03189459	In-Home Care for Patients With Parkinson's Disease	COMPLETED
Mobilizing Community Hypertension Access Pilot	Hypertension	NA	NCT07547345	Mobilizing Community Hypertension Access Pilot	RECRUITING
Flow Detection System	Migraine	Phase 3	NCT01773252	PFO Detection — Right to Left Cardiac Shunt Detection	TERMINATED
ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	Alzheimer	À vérifier	NCT01078636	ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	COMPLETED
A Study of Brain Aging in Vietnam War Veterans	Alzheimer	À vérifier	NCT01687153	A Study of Brain Aging in Vietnam War Veterans	COMPLETED